AGNG


Aging Population ETF

Fund Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

Fund Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Why AGNG?

High Growth Potential

AGNG enables investors to access high growth potential through companies at the leading edge of a long-term, structural demographic trend affecting multiple sectors of the global economy.

Unconstrained Approach

AGNG's composition transcends classic sector, industry, and geographic classifications by tracking an emerging theme.

ETF Efficiency

In a single trade, AGNG delivers access to dozens of companies with high exposure to the Longevity theme.

Fund Details As of 04/15/21

Key Facts

Ticker AGNG
Inception Date 05/09/16
CUSIP 37954Y772
ISIN US37954Y7720
Bloomberg Index Ticker ILNGRNT
Primary Exchange Nasdaq
Number of Holdings 99

Stats & Fees

Net Assets $47,655,000
Net Asset Value (NAV) $28.71
Shares Outstanding 1,660,000
Total Expense Ratio 0.50%

Distributions

30-Day SEC Yield 0.37%
Distribution Frequency Semi-Annually

Fund Prices As of 04/15/21

NAV $28.71 Daily Change $0.37 1.31%
Market Price $28.75 Daily Change $0.39 1.38%
30-Day Median Bid-Ask Spread 0.31%

Performance History

As of recent month & quarter-end (03/31/21)
As of recent month & quarter-end (03/31/21)
Fund NAV Market Price Index
1 Year 37.23% 37.70% 37.64%
3 Years 12.81% 12.79% 13.07%
Since Inception 13.85% 14.40% 14.16%
1 Year 37.23% 37.70% 37.64%
3 Years 12.81% 12.79% 13.07%
Since Inception 13.85% 14.40% 14.16%
Year-to-Date -1.25% -0.61% -1.22%
1 Month -0.36% -0.22% -0.37%
3 Months -1.25% -0.61% -1.22%
Since Inception 88.63% 93.16% 91.25%
Year-to-Date -1.25% -0.61% -1.22%
1 Month -0.36% -0.22% -0.37%
3 Months -1.25% -0.61% -1.22%
Since Inception 88.63% 93.16% 91.25%

Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance of the Fund, when observed, is unusual and investors should not expect such performance to be repeated.

Fund Characteristics As of 03/31/21

Return on Equity 12.40%
Weighted Avg. Market Cap 42,145 M
2020 2021
Price-to-earnings 29.84 29.03
Price-to-book value 3.76 3.45

Source: AltaVista Research, LLC

Fund Risk Stats As of 03/31/21

Versus Beta
S&P 500 0.83
MSCI EAFE 0.77
MSCI Emg. Mkts 0.63
Standard Deviation 18.10%

Source: AltaVista Research, LLC

Sector Breakdown As of 03/31/21

% of Net Assets
Health Care 93.1
Real Estate 5.7
Information Technology 0.8
Industrials 0.3
Other/Cash 0.1

Source: AltaVista Research, LLC

Country Breakdown As of 03/31/21

% of Net Assets
United States 61.4
Denmark 6.2
Switzerland 5.6
Japan 5.5
China 4.5
Ireland 3.3
South Korea 3.0
Britain 2.5
France 1.9
Germany 1.6
Belgium 1.3
Other/Cash 3.2

Source: AltaVista Research, LLC

Top Holdings As of 04/16/21

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
3.09 EW EDWARDS LIFESCIENCES CORP 2567116 89.02 14,479 1,288,920.58
3.09 BMY BRISTOL-MYERS SQUIBB CO 2126335 65.46 19,683 1,288,449.18
3.09 BSX BOSTON SCIENTIFIC CORP 2113434 40.91 31,472 1,287,519.52
3.09 REGN REGENERON PHARMACEUTICALS 2730190 502.60 2,558 1,285,650.80
3.06 NOVOB DC NOVO NORDISK A/S-B BHC8X90 72.37 17,609 1,274,431.64
3.06 MDT MEDTRONIC PLC BTN1Y11 125.91 10,110 1,272,950.10
3.03 LLY ELI LILLY & CO 2516152 189.25 6,673 1,262,865.25
3.03 AMGN AMGEN INC 2023607 255.71 4,936 1,262,184.56
3.01 SYK STRYKER CORP 2853688 257.13 4,882 1,255,308.66
3.00 AZN ASTRAZENECA PLC-SPONS ADR 2989044 50.74 24,617 1,249,066.58
2.97 ABBV ABBVIE INC B92SR70 107.91 11,484 1,239,238.44
2.95 RO SW ROCHE HOLDING AG-BR 7108918 351.71 3,493 1,228,508.19
2.91 JNJ JOHNSON & JOHNSON 2475833 162.24 7,476 1,212,906.24
2.91 4519 JP CHUGAI PHARMA CO 6196408 39.70 30,531 1,212,093.19
2.35 BIIB BIOGEN INC 2455965 270.31 3,622 979,062.82
2.21 DXCM DEXCOM INC B0796X4 400.04 2,302 920,892.08
2.17 068270 KS CELLTRION INC B0C5YV1 275.90 3,275 903,508.97
2.11 ALC SW ALCON INC BJT1GR5 73.98 11,897 880,089.30
2.04 ZBH ZIMMER BIOMET HO 2783815 171.88 4,952 851,149.76
1.80 WELL WELLTOWER INC BYVYHH4 75.69 9,919 750,769.11
1.62 4543 JP TERUMO CORP 6885074 37.37 18,047 674,347.31
1.61 4503 JP ASTELLAS PHARMA INC 6985383 15.14 44,200 669,407.71
1.60 BGNE BEIGENE LTD-ADR BYYWPW6 305.54 2,183 666,993.82
1.56 3692 HK HANSOH PHARMACEU BJYKB72 4.61 141,000 649,656.69
1.50 SGEN SEAGEN INC BLPK4D2 145.50 4,306 626,523.00
1.32 GMAB DC GENMAB A/S 4595739 351.36 1,561 548,469.31
1.27 FME GR FRESENIUS MEDICA 5129074 75.93 6,952 527,837.65
1.26 EXAS EXACT SCIENCES CORP 2719951 130.04 4,024 523,280.96
1.24 CASH 1.00 516,924 517,085.66
1.24 STMN SW STRAUMANN HOLDING AG-REG 7156832 1,358.62 379 514,915.39
1.18 VTR VENTAS INC 2927925 55.41 8,890 492,594.90
1.15 TFX TELEFLEX INC 2881407 432.56 1,109 479,709.04
1.13 NVCR NOVOCURE LTD BYSS4X4 192.50 2,437 469,122.50
1.12 PODD INSULET CORP B1XGNW4 297.00 1,572 466,884.00
1.09 UCB BB UCB SA 5596991 98.52 4,613 454,469.69
1.06 SOON SW SONOVA HOLDING AG-REG 7156036 288.48 1,538 443,584.41
1.03 INCY INCYTE CORP 2471950 82.68 5,214 431,093.52
1.00 SN/ LN SMITH & NEPHEW PLC 0922320 19.97 20,839 416,152.17
0.85 ABMD ABIOMED INC 2003698 330.53 1,072 354,328.16
0.72 DVA DAVITA INC 2898087 113.11 2,634 297,931.74
0.71 GN DC GN STORE NORD A/S 4501093 87.83 3,382 297,045.66
0.67 DEMANT DC DEMANT A/S BZ01RF1 49.09 5,721 280,826.55
0.65 853 HK MICROPORT SCIENTIFIC CORP B676TW7 6.34 43,000 272,556.45
0.65 COH AU COCHLEAR LTD 6211798 173.06 1,555 269,105.70
0.55 AMP IM AMPLIFON SPA B14NJ71 42.40 5,379 228,044.96
0.53 AMED AMEDISYS INC 2024332 282.96 780 220,708.80
0.51 UTHR UNITED THERAPEUTICS CORP 2430412 203.73 1,051 214,120.23
0.51 NBIX NEUROCRINE BIOSC 2623911 96.58 2,217 214,117.86
0.49 OHI OMEGA HEALTHCARE 2043274 37.31 5,467 203,973.77
0.46 ORP FP ORPEA 7339451 126.74 1,524 193,156.36
0.42 EXEL EXELIXIS INC 2576941 23.59 7,348 173,339.32
0.38 HALO HALOZYME THERAPEUTICS INC 2975098 46.41 3,401 157,840.41
0.37 DNLI DENALI THERAPEUTICS INC BD2B4V0 54.01 2,846 153,712.46
0.37 LHCG LHC GROUP INC B06DT50 203.52 750 152,640.00
0.36 INGN INOGEN INC BJSVLL5 65.73 2,293 150,718.89
0.31 BPMC BLUEPRINT MEDICINES CORP BWY52P3 95.20 1,359 129,376.80
0.31 SILK SILK ROAD MEDICAL INC BGHVXJ7 52.97 2,412 127,763.64
0.31 FGEN FIBROGEN INC BSDRYR8 19.91 6,381 127,045.71
0.30 TCMD TACTILE SYSTEMS BZB1XF2 54.43 2,316 126,059.88
0.30 8086 JP NIPRO CORP 6641599 12.69 9,914 125,821.20
0.30 2186 HK LUYE PHARMA GROUP LTD BNQ4GF3 0.59 213,147 124,816.61
0.30 OMER OMEROS CORP B4NB858 18.37 6,779 124,530.23
0.30 HRTX HERON THERAPEUTICS INC BJ0XLZ3 17.87 6,950 124,196.50
0.30 AGIO AGIOS PHARMACEUTICALS INC BCBVTX1 54.69 2,269 124,091.61
0.30 MMSI MERIT MEDICAL SYSTEMS INC 2580555 61.78 2,005 123,868.90
0.30 4547 JP KISSEI PHARM CO 6494061 21.83 5,640 123,098.84
0.30 ACAD ACADIA PHARMACEU 2713317 21.15 5,804 122,754.60
0.30 ITGR INTEGER HOLDINGS CORP BD06LM7 93.05 1,319 122,732.95
0.29 NUVA NUVASIVE INC B00GJC2 69.02 1,778 122,717.56
0.29 LIVN LIVANOVA PLC BYMT0J1 81.34 1,501 122,091.34
0.29 AED BB AEDIFICA B1G5XP1 121.35 1,003 121,716.30
0.29 RYM NZ RYMAN HEALTHCARE LTD 6161525 10.33 11,717 121,030.08
0.29 EKTAB SS ELEKTA AB-B SHS B0M42T2 13.79 8,761 120,802.01
0.29 ANGO ANGIODYNAMICS INC B00CR04 24.23 4,964 120,277.72
0.29 GKOS GLAUKOS CORP BYMWL19 85.02 1,414 120,218.28
0.29 TBPH THERAVANCE BIOPHARMA INC BMNDK09 21.71 5,510 119,622.10
0.29 CSH-U CN CHARTWELL RETIRE B8S8C94 9.75 12,263 119,607.91
0.29 LTC LTC PROPERTIES INC 2498788 43.41 2,750 119,377.50
0.29 1302 HK LIFETECH SCIENTIFIC CORP BV9FKS0 0.49 244,000 119,331.53
0.29 ENSG ENSIGN GROUP INC/THE B1YWPP8 92.07 1,296 119,322.72
0.29 KORI FP KORIAN B1HKRM0 37.54 3,171 119,051.15
0.29 ARNA ARENA PHARMACEUTICALS INC BF3N4P3 65.90 1,805 118,949.50
0.29 RDUS RADIUS HEALTH INC BM68KK1 19.71 6,034 118,930.14
0.29 NHI NATL HEALTH INVESTORS INC 2626125 73.81 1,608 118,686.48
0.28 BLUE BLUEBIRD BIO INC BBFL7S1 28.28 4,158 117,588.24
0.28 BKD BROOKDALE SR B0PZN33 6.79 17,242 117,073.18
0.28 MNKD MANNKIND CORP BF081J4 4.18 27,770 116,078.60
0.28 NHC NATIONAL HEALTHCARE CORP 2139731 73.11 1,585 115,879.35
0.28 PHM SM PHARMA MAR SA BMW2GT8 111.58 1,037 115,751.82
0.28 ATEC ALPHATEC HOLDINGS INC BD60BG7 16.77 6,902 115,746.54
0.28 SBRA SABRA HEALTH CAR B5NLBP6 17.84 6,488 115,745.92
0.28 EPZM EPIZYME INC B9Z1QZ7 8.10 14,243 115,297.09
0.28 2500 HK VENUS MEDTECH -H BL6V047 8.17 14,100 115,141.67
0.28 DHC DIVERSIFIED HEAL BKRN595 4.61 24,906 114,816.66
0.28 PNTG PENNANT GROUP INC/THE BKTC976 42.09 2,727 114,779.43
0.27 1858 HK BEIJING CHUNLI-H BVVPXP6 2.34 48,500 113,729.17
0.26 AERI AERIE PHARMACEUTICALS INC BFRTDG1 17.25 6,318 108,985.50
0.26 ALEC ALECTOR INC BJ4LDC4 17.80 6,105 108,669.00
0.26 1789 HK AK MEDICAL HOLDINGS LTD BFD6SZ0 1.22 88,000 107,480.74
0.24 AMRN AMARIN CORP PLC -ADR 2301938 5.02 19,927 100,033.54
Holdings are subject to change.


Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.